Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Francesca Kum
Clinical outcomes of anterior prostate cancers treated with robotic assisted radical prostatectomy
4 DISCUSSION This study is the largest prospective cohort analysis performed to date assessing the pathological and clinical features of anterior prostate cancers, peri- and postoperatively. Not only in the number of cases of anterior prostate cancer analysed prospectively but also in the depth of variables. Assessing the demographic and clinical characteristic data, statistically significant differences were identified within the perioperative data collected.
Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID‐19 using local anaesthesia transperineal biopsy
Introduction The COVID‐19 pandemic is impacting all urological cancer services. On 19 March 2020, the BAUS provided pragmatic guidance for prostate cancer diagnostic services (Table 1) [1]. Table 1. BAUS guidance on the management of the prostate cancer diagnostic pathway during the COVID‐19 pandemic []. COVID‐19 policy recommendation 1: PSA >20 µg/mL (Category 1): Patients with a PSA >20 ng/mLwith identified metastatic disease to initiate hormone therapy.
Targeted and systematic cognitive freehand‐guided transperineal biopsy: is there still a role for systematic biopsy?
Original Article Anoushka Neale Corresponding Author E-mail address: anoushka.neale@nhs.net https://orcid.org/0000-0002-1134-5819 Department of Urology, Guy's and Saint Thomas' NHS Foundation Trust, London, UK Correspondence: Anoushka Neale, Department of Urology, Guy's and St Thomas' NHS Foundation Trust, 1st Floor Southwark Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting
Original Article Oussama Elhage Corresponding Author E-mail address: oussama.elhage@kcl.ac.uk https://orcid.org/0000-0002-9604-9583 Department of Urology, Guy's at St Thomas’ Hospitals, London, UK King's College London School of Medicine, London, UK Correspondence: Oussama Elhage, Consultant Urological Surgeon, Department of Urology, Guy's and St Thomas’ NHS Foundation Trust, 1st Floor Southwark Wing, Guy's Hospital, Great Maze Pond, London SE1, UK.
Smoking Cessation Intervention for Head and Neck Patients: a Comparison in Practice between ENT Consultants and Trainees
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Introduction: Smoking at the time of a cancer diagnosis increases cancer related morbidity and mortality, while smoking cessation can reverse small T1 laryngeal tumours[x]and improve outcomes in those who cease smoking within 3 months of diagnosis. 20% of patients in the Head & Neck 2-week-wait clinic are smokers.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Francesca
Contact Francesca, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack